Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam

J Antimicrob Chemother. 2017 Apr 1;72(4):1262-1263. doi: 10.1093/jac/dkw526.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Infective Agents, Urinary / therapeutic use*
  • Cephalosporins / therapeutic use*
  • Drug Resistance, Multiple, Bacterial / drug effects*
  • Humans
  • Male
  • Middle Aged
  • Penicillanic Acid / analogs & derivatives*
  • Penicillanic Acid / therapeutic use
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects*
  • Skin Diseases, Bacterial / drug therapy*
  • Skin Diseases, Bacterial / microbiology
  • Soft Tissue Infections / drug therapy*
  • Soft Tissue Infections / microbiology
  • Tazobactam

Substances

  • Anti-Infective Agents, Urinary
  • Cephalosporins
  • ceftolozane, tazobactam drug combination
  • Penicillanic Acid
  • Tazobactam